13-Valent vaccine serotype pneumococcal community acquired pneumonia in adults in high clinical risk groups

This analysis suggests that in the UK, the burden of PCV13 disease is greater in adults outside the traditional 'at-risk' groups compared to adults in 'at-risk' groups.